Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Naltrexone for the management of alcohol dependence.

× No keyword cloud information.

41 in total

Review 1. New therapies for alcohol problems: application to primary care.

Authors: D A Fiellin; M C Reid; P G O'Connor
Journal: Am J Med Date: 2000-02-15 Impact factor: 4.965

Review 2. Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders.

Authors: William R Miller; Paula L Wilbourne
Journal: Addiction Date: 2002-03 Impact factor: 6.526

3. Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients.

Authors: H M Pettinati; J R Volpicelli; J D Pierce; C P O'Brien
Journal: J Addict Dis Date: 2000

4. Naltrexone in the treatment of alcohol dependence.

Authors: J H Krystal; J A Cramer; W F Krol; G F Kirk; R A Rosenheck
Journal: N Engl J Med Date: 2001-12-13 Impact factor: 91.245

5. Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism.

Authors: R F Anton; D H Moak; P K Latham; L R Waid; R J Malcolm; J K Dias; J S Roberts
Journal: J Clin Psychopharmacol Date: 2001-02 Impact factor: 3.153

6. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

Authors: Stephanie S O'Malley; Suchitra Krishnan-Sarin; Conor Farren; Rajita Sinha; Mary Jeanne Kreek
Journal: Psychopharmacology (Berl) Date: 2002-01-22 Impact factor: 4.530

7. Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials.

Authors: C Streeton; G Whelan
Journal: Alcohol Alcohol Date: 2001 Nov-Dec Impact factor: 2.826

8. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.

Authors: H R Kranzler; J Van Kirk
Journal: Alcohol Clin Exp Res Date: 2001-09 Impact factor: 3.455

9. Carbohydrate-deficient transferrin: validity of a new alcohol biomarker in a sample of patients with diabetes and hypertension.

Authors: Michael Fleming; Marlon Mundt
Journal: J Am Board Fam Pract Date: 2004 Jul-Aug

Review 10. Biochemical alcohol screening in primary health care.

Authors: Peter M Miller; Raymond F Anton
Journal: Addict Behav Date: 2004-09 Impact factor: 3.913

31 in total

1. Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of mu opioid receptor selective antagonists.

Authors: Saheem A Zaidi; Christopher K Arnatt; Hengjun He; Dana E Selley; Philip D Mosier; Glen E Kellogg; Yan Zhang
Journal: Bioorg Med Chem Date: 2013-09-04 Impact factor: 3.641

Review 2. Alcohol-induced changes in the brain as assessed by MRI and CT.

Authors: Sasikhan Geibprasert; Massimo Gallucci; Timo Krings
Journal: Eur Radiol Date: 2009-12-08 Impact factor: 5.315

3. Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone.

Authors: Jeanette M Tetrault; Janet P Tate; Kathleen A McGinnis; Joseph L Goulet; Lynn E Sullivan; Kendall Bryant; Amy C Justice; David A Fiellin
Journal: Alcohol Clin Exp Res Date: 2011-07-28 Impact factor: 3.455

4. An inpatient treatment and discharge planning protocol for alcohol dependence: efficacy in reducing 30-day readmissions and emergency department visits.

Authors: Jennie Wei; Triveni Defries; Mia Lozada; Natalie Young; William Huen; Jacqueline Tulsky
Journal: J Gen Intern Med Date: 2014-08-05 Impact factor: 5.128

5. Relapse to drug seeking following prolonged abstinence: the role of environmental stimuli.

Authors: R A Fuchs; H C Lasseter; D R Ramirez; X Xie
Journal: Drug Discov Today Dis Models Date: 2008

Review 6. Advancing addiction treatment: what can we learn from animal studies?

Authors: Peter H Wu; Kalynn M Schulz
Journal: ILAR J Date: 2012

Review 7. Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

Authors: Natalya C Maisel; Janet C Blodgett; Paula L Wilbourne; Keith Humphreys; John W Finney
Journal: Addiction Date: 2012-10-17 Impact factor: 6.526

8. The Reasons for Heavy Drinking Questionnaire: Factor Structure and Validity in Alcohol-Dependent Adults Involved in Clinical Trials.

Authors: Zachary W Adams; Joseph P Schacht; Patrick Randall; Raymond F Anton
Journal: J Stud Alcohol Drugs Date: 2016-03 Impact factor: 2.582

9. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.

Authors: Raymond F Anton; Patricia Latham; Konstantin Voronin; Sarah Book; Michaela Hoffman; James Prisciandaro; Emily Bristol
Journal: JAMA Intern Med Date: 2020-05-01 Impact factor: 21.873

10. Naltrexone may block euphoria-like placebo effect.

Authors: Andriy V Samokhvalov; Islam Gamaleddin; Beth Sproule; Jürgen Rehm
Journal: BMJ Case Rep Date: 2013-08-07